PB2607: OBESITY IMPAIRS RESPONSE TO FIRST-LINE HIGH-DOSE DEXAMETHASONE IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA.
Main Authors: | Gege Feng, Xiaoyu Zhang, Qiang Liu, Shuwen Wang, Jun Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000977116.42601.f3 |
Similar Items
-
PB2307: A MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF ROMIPLOSTIM PLUS DEXAMETHASONE VS DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY IMMUNE THROMBOCYTOPENIA
by: M. E. Mingot Castellano, et al.
Published: (2022-06-01) -
Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia
by: Kaniye Aydın, et al.
Published: (2022-06-01) -
First-line Therapy for Immune Thrombocytopenia: Time for Change
by: Roger E. G. Schutgens
Published: (2022-10-01) -
First line treatment of adult patients with primary immune thrombocytopenia: a real-world study
by: Liang Wang, et al.
Published: (2020-01-01) -
PB2315: EFFICACY AND SAFETY OF TWO DIFFERENT LOW-DOSE RITUXIMAB REGIMENS FOR CHINESE CHILDREN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA
by: X. Zhu
Published: (2022-06-01)